Profile photo Lois Daamen

Lois Daamen

Associate Professor

Strategic program(s):

Biography

[will follow shortly]

Research interests

AI for Early Detection of Isolated Local Pancreatic Cancer Recurrence

In collaboration with Datacation, UMC Utrecht is developing an artificial intelligence (AI) solution for the early detection of isolated local pancreatic cancer recurrence. This project is co-funded by the European Union through the Kansen voor West programme.

Background and challenge

Pancreatic cancer is a highly aggressive malignancy, with >80% of patients developing disease recurrence within two years after surgical resection. Early, accurate detection of recurrence is critical for timely treatment initiation and to reduce uncertainty for patients with regard to their diagnosis and corresponding prognosis. However, on postoperative CT imaging, distinguishing between tumor recurrence and postoperative fibrotic tissue remains challenging, even for experienced radiologists, as both can present with similar radiological characteristics.

AI-based image analysis offers a promising solution by enabling the detection of subtle imaging patterns and facilitating the rapid analysis of large volumes of scans.

Methodological approach and collaboration

Within this collaboration, Datacation has developed an AI model capable of automatic pancreas recognition and segmentation on CT scans after resection. Postoperative anatomical variability presents a substantial challenge: surgical resection often alters pancreatic anatomy, rendering conventional segmentation models suboptimal.

To address this, the developed model employs an encoder-decoder architecture enhanced with an attention mechanism, allowing it to better adapt to inter-patient variability. This work has resulted in a peer-reviewed scientific publication (https://pubmed.ncbi.nlm.nih.gov/41307673/).

Building on this foundation, ongoing work focuses on developing an AI model for automated detection of tumor recurrence following surgery. A key aspect of this development is model explainability. The system is designed to provide visual explanations, highlighting regions within CT images that contribute to classification decisions (e.g., fibrosis versus suspected tumor recurrence). These visualizations aim to support radiologists in interpreting model outputs and enhance trust in clinical decision-making.

Expected impact

This project represents an active collaboration between UMC Utrecht and Datacation, supported by European Union funding. The ultimate goal is to integrate the final AI model into clinical workflows, where it can assist radiologists in evaluating postoperative CT scans.

By enabling faster and more accurate detection of pancreatic cancer recurrence, the approach has the potential to facilitate earlier therapeutic intervention and reduce uncertainty for patients. This may contribute to improved treatment outcomes, increased survival rates, and enhanced quality of life for patients.

 

      

Strategic program(s):

Contact

Research groups

Evaluation of imaging and image-guided Interventions

Research aim

The pace of innovation in (AI driven) imaging/image-guided interventions in oncology is high; the window of opportunity for evaluation narrow. We aim to learn from every patient, in order to facilitate evidence-based implementation of innovation.

Go to group

Recent publications

Addressing Incomplete Data in Survival and Quality of Life Prediction Aneta Lisowska, Floris den Hengst, Syed Ihtesham Hussain Shah, Annette ten Teije, Omar Bohoudi, Pauline Vissers, Mahsoem Ali, Laura Leeuwenburgh, Martijn Stommel, Amber Lamoré, Inez Verpalen, Marjolein Homs, Bas Groot Koerkamp, Judith De Vos-Geelen, Sven Mieog, Jeanin E. van Hooft, Lois Daamen, Vincent E. De Meijer, Hanneke Wilmink, Hanneke van Laarhoven, Marc Besselink, Geert Kazemier,
2027, p.28-37
The European Multidisciplinary Evidence-Based Guideline on Pancreatic Cancer Laura C Leeuwenburgh, Magdalena Holze, Dena Akhoundzadeh, Adnan Alsourani, Ricardo Alvarez Jimenez, Paul C M Andel, Charlotte Baggerman van Houweninge, Alberto Balduzzi, Caro L Bruna, Fabio Casciani, Alice Cattelani, Aniek E van Diepen, Heleen Driessens, Daphne H M Droogh, Jeska A Fritzsche, Eline van Gansewinkel, Luana Genova, Anne M Gehrels, Gonzalo Gómez Dueñas, Riccardo Guastella, Lis S M Hoeijmakers, Tijs J Hoogteijling, Ammar A Javed, Berk Kaan Aktas, Benedict Kinny-Köster, Amber Lamoré, K Seng Liem, Gabriella Lionetto, Lorenzo Lo Faro, Lisanne Lutter, Manuela Mastronardi, Carlo H Maurer, Roberto Montorsi, Julian Musa, Ingmar F Rompen, Jacobien C M Scheepens, Dana Sochorová, Thomas F Stoop, Nuray Tezcan, Bas A Uijterwijk, Roberta Vella, Federica Vernuccio, Rogier P Voermans, Mohammad Abu Hilal, Volkan Adsay, Hana Algül, Valentina Ambrosini, Livia Archibugi, Eva Backman, Lois A Daamen,
Clinical and public health guidelines, 2026, vol. 3
Prognostic host phenotypes based on body composition and systemic inflammation predict survival in patients with resected pancreatic and periampullary cancer Nicole D Hildebrand, David P J van Dijk, Jisce R Puik, Anne Claire Henry, Paul Andel, Esther N Dekker, Nynke Michiels, Lloyd Brandts, Ralph Brecheisen, Leonard Wee, Sebastiaan Festen, Koop Bosscha, Jennifer M J Schreinemakers, Fennie Wit, Marion B van der Kolk, J Sven D Mieog, Mike S L Liem, Vincent B Nieuwenhuijs, Ignace H J T de Hingh, Judith de Vos-Geelen, Jens T Siveke, Joost M Klaase, Vincent E de Meijer, Robbert J de Haas, Bas Groot Koerkamp, Babs M Zonderhuis, Geert Kazemier, Marc G Besselink, I Quintus Molenaar, Lois A Daamen, Marcel den Dulk, Sander S Rensen, Hjalmar C van Santvoort, Steven W M Olde Damink,
European Journal of Cancer, 2026, vol. 245
Stereotactic body radiotherapy in pancreatic ductal adenocarcinoma Jacobien C.M. Scheepens, Guus Grimbergen, Lois A. Daamen
Annals of Pancreatic Cancer, 2026, vol. 9
The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localized pancreatic cancer J. C.M. Scheepens, K. J. Prinsze, L. G. van Geest, M. G. Besselink, B. A. Bonsing, A. M.E. Bruynzeel, G. A. Cirkel, H. D. Heerkens, I. H. de Hingh, M. Y.V. Homs, J. E. van Hooft, H. W.M. van Laarhoven, L. C. Leeuwenburgh, V. E. de Meijer, G. J. Meijer, I. Q. Molenaar, P. G. Noordzij, H. M.U. Peulen, H. C. van Santvoort, M. W.J. Stommel, R. C. Verdonk, P. A.J. Vissers, C. van Vliet, J. de Vos-Geelen, J. W. Wilmink, M. P.W. Intven, L. A. Daamen, G. Grimbergen,
European journal of cancer, 2026, vol. 242
Learning from every patient Maarten J Kamphuis, Irene C van der Schaaf, Roxanne Gal, Joanne M van der Velden, J P Maarten Burbach, Nicolien Kasperts, Jochem R N van der Voort van Zyp, Joost J C Verhoeff, Danny A Young-Afat, Martijn P W Intven, Sofie A M Gernaat, Frederieke H van der Baan, Geraldine R Vink, Miriam Koopman, Faye J Raaijmakers, Fia Cialdella, Tariq A Lalmahomed, Jasmijn M Westerhoff, Renée Hovenier, Eline H Huele, Frederik R Teunissen, Dieuwke R Mink van der Molen, Sophie R de Mol van Otterloo, Merle Hattink, Mathijs L Tomassen, Lois A Daamen, Helena M Verkooijen
Journal of Clinical Epidemiology, 2026, vol. 195